Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Return on Invested Capital (2016 - 2025)

Ptc Therapeutics has reported Return on Invested Capital over the past 10 years, most recently at 5.15% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 5.15% for Q4 2025, down 545.0% from a year ago — trailing twelve months through Dec 2025 was 5.15% (down 545.0% YoY), and the annual figure for FY2025 was 1.36%, down 171.0%.
  • Return on Invested Capital for Q4 2025 was 5.15% at Ptc Therapeutics, down from 4.65% in the prior quarter.
  • Over the last five years, Return on Invested Capital for PTCT hit a ceiling of 108.71% in Q1 2022 and a floor of 5.15% in Q4 2025.
  • Median Return on Invested Capital over the past 5 years was 0.27% (2024), compared with a mean of 5.15%.
  • Biggest five-year swings in Return on Invested Capital: soared 10942bps in 2022 and later crashed -10736bps in 2023.
  • Ptc Therapeutics' Return on Invested Capital stood at 1.98% in 2021, then skyrocketed by 195bps to 1.88% in 2022, then crashed by -42bps to 1.08% in 2023, then plummeted by -72bps to 0.31% in 2024, then tumbled by -1776bps to 5.15% in 2025.
  • The last three reported values for Return on Invested Capital were 5.15% (Q4 2025), 4.65% (Q3 2025), and 3.67% (Q2 2025) per Business Quant data.